Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

17.50
Delayed Data
As of Aug 18
 -0.06 / -0.34%
Today’s Change
4.03
Today|||52-Week Range
21.85
+60.40%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close17.56
Today’s open17.46
Day’s range16.90 - 17.76
Volume586,946
Average volume (3 months)808,681
Market cap$726.8M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+17.75%
Earnings growth (this year)+45.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+124.95%
P/E ratioNM
Price/Sales4.49
Price/Book5.02

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.30-1.28%
ZIOPZIOPHARM Oncology In...-0.16-3.11%
VNDAVanda Pharmaceutical...-0.15-0.93%
HSKAHeska Corp-0.80-0.81%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$82.7M
Annual profit (last year)-$142.1M
Net profit margin-171.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts